Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years
Not Applicable
- Conditions
- Advanced Hip Disease
- Interventions
- Device: THA using 4th generation CoC
- Registration Number
- NCT01838096
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty ("THA") in patients younger than 30 years.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
- younger than 30 years
- advanced hip disease
Read More
Exclusion Criteria
- older than 30 years
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description THA THA using 4th generation CoC -
- Primary Outcome Measures
Name Time Method survival rate of 4th generation ceramic-on-ceramic THA 5 years survival rate of 4th generation ceramic-on-ceramic THA end point for best senario ; any reoperation end point for moderate senario ; loosening end point for worst senario ; osteolysis
- Secondary Outcome Measures
Name Time Method